{"schema":"hottub-news/story/v1","story":"st_6appuexgjdhfcqxcycxq","title":"拜耳藥廠斥22億美元在美建新廠房 創造逾千職位","title_en":"Bayer Pharmaceuticals invests $2.2 billion to build a new plant in the U.S., creating over a thousand jobs","outlets":1,"brief":null,"page":"https://hottub.news/stories/bayer-pharmaceuticals-invests-2-2-billion-to-build-a-new-plant-in-the-u-6appuexgjd","count":1,"items":[{"id":"n_6appuexgjdhfcqxcycxq","seq":1421591,"kind":"article","title":"拜耳藥廠斥22億美元在美建新廠房 創造逾千職位","title_en":"Bayer Pharmaceuticals invests $2.2 billion to build a new plant in the U.S., creating over a thousand jobs","url":"https://www.bastillepost.com/hongkong/article/16897744-%e6%8b%9c%e8%80%b3%e8%97%a5%e5%bb%a0%e6%96%a522%e5%84%84%e7%be%8e%e5%85%83%e5%9c%a8%e7%be%8e%e5%bb%ba%e6%96%b0%e5%bb%a0%e6%88%bf-%e5%89%b5%e9%80%a0%e9%80%be%e5%8d%83%e8%81%b7%e4%bd%8d","summary":"拜耳藥廠周五公布，計劃在美國俄亥俄州新奧爾巴尼，投資22億美元興建新的藥物生產設施。這次項目是拜耳長遠增長策略的核心部分，亦是其在美國最大藥物市場，對創新及病人用藥的承諾。過去五年，拜耳在美國藥物研發及生產方面，已投放超70億美元。 拜耳行政總裁安德森表示，拜耳一直視美國為主要生產基地及創新樞紐，這次具里程碑意義的投資，突顯公司承諾。他指出，新設施將匯聚生產專業知識及熟練勞動力，加強公司向美國及海外病人，提供創新優質藥物的能力。 拜耳藥業全球首席營運官兼拜耳美國區總裁古思表示，美國是拜耳藥業部門的關鍵市場。這次擴張是發展藥業業務的另一個重要步驟，以滿足美國這個增長最快藥物市場，以及其他地區客戶及病人的需求。 預計新設施將創造高技能職位，並支持俄亥俄州的經濟發展。 拜耳預計在新奧爾巴尼國際商業園，創造約600個高價值職位，並在設施建造期間，提供約1,500個建築職位。…","published":"2026-10-02T19:11:25Z","seen":"2026-10-02T20:01:09Z","lang":"zh","country":"HK","source":{"id":"kite-bastillepost-com-c7bf21","name":"bastillepost.com","domain":"bastillepost.com"},"via":"kite-bastillepost-com-c7bf21","topics":["商業事","投資","拜耳","美國","職位","藥廠"],"authors":["AP翻譯"],"entities":[{"id":"Q152051","name":"Bayer","type":"org"}],"story":"st_6appuexgjdhfcqxcycxq","category":"economy-business","category_p":0.9599999785423279,"sentiment":"positive","tone":0.5699999928474426,"political":0.09000000357627869}]}